Cannabis Corner: All three keep adding new products

Article Excerpt

First, the good news: cannabis legalization will eventually lead to some great business successes. The bad news is that only a few of the multitude of cannabis stocks today will pay off for investors. Consumer cannabis demand is high, but growing and distributing it across multiple markets is more difficult. With “Cannabis Corner,” we focus on quality stocks that are most likely to emerge as winners in the “Wild West” of marijuana investing. CRONOS GROUP $9.50 (Toronto symbol CRON; TSINetwork Rating: Speculative) (cronosgroup.com; Shares outstanding: 356.2 million; Market cap: $3.4 billion; TSI Cannabis Quality Rating [CQR]: ) grows and sells medical and recreational cannabis. In the U.S., Cronos has now expanding it range of non-intoxicating cannabidiol (CBD) products with new flavoured oils. They’re sold under its hemp CBD brand, Lord Jones. The company will also soon begin selling a Lord Jones branded hemp-derived CBD infused Lip Balm. Its Whole Plant Formula CBD Lip Balm will contain 25mg of U.S. hemp-derived CBD…